The PennZone

  • Home
  • Non-profit
  • Health
  • Books
  • Marketing
  • Entertainment
  • Sports
  • Business
  • Legal

Good news! The COVID-19 vaccine is coming to Whittier Health Network in Massachusetts
The PennZone/10102000

Trending...
  • Communities In Schools of Eastern Pennsylvania Honors United Way and Local Leaders
  • Conservative Latinos for PA PAC Endorses Stacy Garrity for Governor: "Pennsylvania's Latino Families Need a Leader Who Delivers"
  • ALight Technology And Services Limited Advances Through Peachscore + Dealum Accelerator and Join LvlUp Labs
Dr Paul Liguori receiving vaccine Philip Arcidi, Treasurer receiving vaccine Whittier Rehabilitation Hospital
The vaccine will be distributed at the Skilled Nursing Facilities, through a partnership with CVS, on a schedule beginning December 29th, and at our Transitional Care Units starting January 4th.

HAVERHILL, Mass. - PennZone -- Here's what you need to know.

At Whittier Health Network, we are dedicated to the well-being of our patients, residents, and staff, and we care for them just like family. That's why we are making sure the COVID-19 vaccine will be available at all of our facilities now that it is approved by the FDA and is currently being distributed.

We will hold a "vaccine clinic" throughout the Whittier Health Network beginning the last week of December. We urge our employees to sign up—for their safety and for the protection of their families and those they care for here at Whittier.

Our Medical staff will be taking the vaccine including our Medical Directors, Dr. Paul Liguori, MD, MRM at Whittier Rehabilitation Hospital Bradford and Dr. John V. Turchetta at Whittier Rehabilitation Hospital Westborough. Senior management at Whittier will also receive the vaccine to show leadership to staff and to show that the vaccine is safe.

More on The PennZone
  • Arizona Pest Control Surpasses $200,000 in Contributions to Southern Arizona High School Sports and Education Programs
  • Beyond Spots & Dots Spreads Holiday Cheer at Old Economy Village's Festival of Trees
  • ZenaTech (NAS DAQ: ZENA) $1 Million in New Utility Contracts- Potential $2.5 Million Follow-On Opportunity Puts Its Drone Business in the Spotlight!
  • New Patient Data Show REQORSA® Activating Cellular Repair Pathways as Roche Collaboration Advances Precision Lung Cancer Strategy for Genprex, Inc
  • Genuine Hospitality, LLC Selected to Operate Holiday Inn Express & Suites Jacksonville – Town Center

The vaccine will be distributed at the Skilled Nursing Facilities, through a partnership with CVS, on a schedule beginning December 29th, and at our Transitional Care Units starting January 4th. Our excellent healthcare staff, patients, and residents take priority and will receive the vaccines first.

A 90% or more adoption rate will significantly reduce outbreaks within each facility. The goal is 100%. It will take many resources to accomplish, but we're up to the task of keeping our family safe.

We also plan to implement CVS's VSafe app, a smartphone-based post-vaccination application that will allow those who have been vaccinated to sign up for monitoring post-vaccine statuses going forward. VSafe incorporates text messages and web surveys and relays information back to the CDC about how those who have been vaccinated are doing post-vaccine.

Visit our blog, where Dr. Paul Liguori at Whittier Rehabilitation Hospital Bradford, explains the vaccine process and how it works within your body: https://hubs.ly/H0CM8cN0.

For more information from the Centers for Disease Control, visit http://www.cdc.gov/coronavirus/2019-ncov/vaccines/index.html.

We look forward to the vaccine helping to protect the well-being of our employees, residents and patients.

Contact
Kathy Soderberg - Chief Compliance Officer
***@whittierhealth.com


Source: Whittier Health Network
Filed Under: Health

Show All News | Disclaimer | Report Violation

0 Comments
1000 characters max.

Latest on The PennZone
  • Household Staffing Recognized as Principal Benefactor of the Nanny Relief Fund
  • KOLBUS America, For All Of Your Hycorr Equipment And Service Needs
  • Heritage at Hopewell Announces New 3.875% Year-One Mortgage Rate Buydown Incentive on Quick Delivery Townhomes (7.11% APR)
  • New TROP2 Research Breakthrough Strengthens REQORSA® Gene Therapy Story as Roche Collaboration Advances Precision Lung Cancer Treatment: Genprex, Inc
  • Rent a Truck or Hire Movers? New Data Shows Fuel Now Makes Up to 40% of DIY Moving Costs
  • TrueNorth Wellness Services Expands Rural Behavioral Health Care in Fulton County with Technology
  • Club Wyndham Research Identifies the "Holiday Rewind Effect": 93% of Parents Recreate Their Own Childhood Holidays for Their Kids
  • IEI Rugged IP66 Panel PC Brings Real-Time Visibility to Heavy-Duty Mining Fleets
  • FDA Approval; Major Milestone for Preservative-Free Ketamine Ahead of FDA Goal Date for Treatment of Suicidal Depression by NRx Pharmaceuticals, Inc
  • Building a Technology Powerhouse-From AI Drones and Global Acquisitions to Defense, Enterprise Software and the Future of Autonomous Operations $ZENA
  • Shelter Structures America backs MATRA Second Life Project to turn retired tent vinyl into homes for displaced families
  • P-Wave Press Announces Becoming Dad: Reflections for New Fathers by L. A. Davenport
  • Logicraft Launches FuelDeck™, AI That Turns Aviation Fuel Tickets Into One Traceable Ledger
  • Inaugural OC Tech Week Draws 3,000 From 12 Countries, Sends Finalist to $1M Startup World Cup
  • Award-Winning American Hotelier Opens Art-Filled Luxury Cottage in Norfolk, England
  • K2 Global / Ozi Amanat Named Among Top 100 AI Venture Capitalists in 2026
  • Dr. Latorial Faison Appointed Poet Laureate of Virginia
  • AdLeverage Brings Golf Simulator Contest and Home Services Marketing Expertise to Service World Expo 2026
  • Cleveland Factory Worker Seeks Funding for AI-Readable Archive Exploring Advanced AI Restraint and Human Survival
  • Ten Ten Ten Announces Maximizing Quality Performance, a Value-Based Care Implementation Guide

Popular on PennZone

  • ASSIST Software Wins Volkswagen Challenge for Automated Quality Inspection - 112
  • RAS AP Consulting Issues National Compliance Alert and Launches Q4 2026 AP Readiness Program Ahead of IRS FIRE → IRIS Cutover - 109
  • New Children's Picture Book "Tippy Tay" Explores the Dangers of Peer Pressure and the Importance of - 108
  • New Children's Picture Book "Adam's Apple" Celebrates Childhood Curiosity and the Funny Misundersta - 106
  • Free Senior Housing Webinar Helps Families Plan for Aging Before a Crisis Forces Difficult Decisions
  • LS2 Partners with Angels Of Dirt's "Next Chapter Racer" Series Celebrating Women and Girls in Motorsports
  • What Mold Remediation Costs in Gettysburg, PA: 2026 Price Ranges by Job Type
  • Pittsburgh Digital Marketing Agency Moves to Babcock Boulevard in the North Hills
  • Creole101 Launches Multilingual Dictionary App with 50,000+ Entries, Vocabulary Games and Haitian Cultural Resources
  • Corner Property Management AAMC Expands Presence with Clover Mill Management Agreement

Similar on PennZone

  • New Patient Data Show REQORSA® Activating Cellular Repair Pathways as Roche Collaboration Advances Precision Lung Cancer Strategy for Genprex, Inc
  • New TROP2 Research Breakthrough Strengthens REQORSA® Gene Therapy Story as Roche Collaboration Advances Precision Lung Cancer Treatment: Genprex, Inc
  • TrueNorth Wellness Services Expands Rural Behavioral Health Care in Fulton County with Technology
  • FDA Approval; Major Milestone for Preservative-Free Ketamine Ahead of FDA Goal Date for Treatment of Suicidal Depression by NRx Pharmaceuticals, Inc
  • Ten Ten Ten Announces Maximizing Quality Performance, a Value-Based Care Implementation Guide
  • CLINIMED Becomes First Liposuction Cannula Maker to Offer 3D and AR Models of Its Cannula Range
  • Major FDA Victory; Preservative-Free Ketamine Approved Ahead of November 10 Goal Date as Commercial Launch Opportunity Comes Into Focus for NRx Pharma
  • Best Black Friday 2026 Deals on Lightweight Foldable Electric Wheelchairs – Save Up to 60%
  • New Research Spotlight, Expanding TUSC2 Science & Strategic Development Milestones Put Gene Therapy Innovation into Focus for Genprex (NAS DAQ: GNPX)
  • Longevity Academy Features Gail Humble, MD of KLOTHO SKIN in the Longevity Leaders Project
Copyright © The PennZone | Theme: OMag by LilyTurf Themes
  • Contribute
  • Privacy Policy
  • Terms of Service
  • Contact Us